
Photo features some of our very own QA/RA experts; Emi Iizuka, Minna Eskola and Parisa Farzanehkari, who all bring their unique expertise to a comprehensive approach that delivers well-informed, nuanced support where it matters most.
Whether you're a startup or a scale-up, Quality Assurance (QA) and Regulatory Affairs (RA) expertise is essential for the safety, credibility, and market success of regulated products. With the right guidance, you can stay focused on innovation while ensuring compliance, minimizing risks, and accelerating your path to market. How do you know what scale of support you should seek? Should you engage a full QA/RA team, or will a single expert suffice? Let’s explore.
If your product involves advanced technologies, such as AI, software as a medical device (SaMD), or hardware with strict safety standards, a full QA/RA team may be necessary. A multidisciplinary team brings diverse perspectives and deep expertise across areas like:
• Usability and clinical evaluation
• Biocompatibility and risk management
• Cybersecurity and AI compliance
For example, Innokas’ QA/RA team includes specialists in each of these domains to ensure comprehensive oversight from concept to CE marking.
European Medtech sector operates within a highly regulated EU framework. While a single expert might suffice for straightforward products, complex regulatory pathways, often under MDR, require a team approach. A full-service partner can also adapt their certified Quality Management System (QMS) to your needs, which is especially valuable if you're starting without one.
Startups and small teams may lean toward hiring a singular expert or fractional support. However, as your portfolio grows, a scalable QA/RA partner offers the flexibility and depth needed to support expansion. Larger companies benefit from faster turnaround times and broader coverage with a full team.
Early-stage companies often begin with foundational QA/RA support. As development progresses, transitioning to a full team ensures readiness for audits, clinical evaluations, and market entry. If your partner also offers product development and manufacturing capabilities, you gain a one-stop-shop to bring your device to market with significantly reduced internal workload.
Ultimately, the choice between a full QA/RA team and a singular expert depends on your product, goals, and growth trajectory. Both models offer value, but the right partner will help you navigate regulatory complexity with confidence.
In the European medtech landscape, where innovation meets strict compliance, outsourcing QA/RA to a trusted partner is a strategic investment. It’s not solely about meeting requirements; it’s about accelerating innovation, reducing risk, and staying competitive.
Whether you're launching a new device or scaling your portfolio, choosing the right QA/RA support can make all the difference. If you're exploring outsourced expertise, let's discuss how a tailored partnership can help bring your innovation to market faster and safer.
Editors

Sandra Hänninen
QA/RA specialist

Parisa Farzanehkari
Clinical affairs specialist
parisa.farzanehkari@innokas.eu

Emi Iizuka
Clinical affairs specialist
Here you can find more of our latest news and insights in this category.
Here you can find more of our latest news, tips and insights.
Here you can find more of our latest news and insights.

Here you can find more of our insights, news and tips.

Here you can find more of our insights, news and tips.